The present invention relates in part to stabilized rice bran extracts
enriched in compounds that have inhibitory activity against certain
anti-inflammatory therapeutic endpoints, such as the COX-1, COX-2 and
5-LOX enzymes. Another aspect of the invention relates to pharmaceutical
compositions comprising the extracts and to methods of treating
inflammatory diseases comprising administering the aforementioned
extracts.